Houston biotech firm adds C-suite roles, opens new research lab in TMC

A clinical-stage biotechnology firm based in Houston is adding executives and expanding its footprint. ImmunoGenesis Inc., which is developing therapies to treat cancerous tumors, is expanding its clinical, business development and research and development teams. The new additions include Federica Pericle, acting chief scientific officer; Dr. Annemarie Moseley, acting chief medical officer; Scott C ullison, acting chief business officer; Matthew Hemberger, senior director of chemistry, manufacturing…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news